| Tuesday May 06 2014 Abstracts selected for presentation will be available online by April 15, 2014 |
|||
| PLENARY SESSIONS | |||
| 08:00-09:00 | PL03 | The new technologies in neurorehabilitation | Patrice L. Weiss, Israel |
| 09:00-10:00 | PL04 | The impact of brain maturation on EEG development in childhood and some electroclinical syndromes (Frank Ford Lecture) | Orvar Eeg-Olofsson, Sweden |
| 10:00-10:30 | COFFEE & POSTER VIEWING / TRADE EXHIBITION | ||
| CONCURRENT SYMPOSIA | |||
| 10:30-12:30 | S05 | Genetics in Infantile Epileptic Encephalopathy | |
| CATARATAS I | Chairs: Heung Dong Kim (South Korea) & Shinichi Hirose (Japan) | ||
| Genetics in infantile epileptic encephalopathy | Heung Dong Kim , Korea, Repub. | ||
| Spectrum of PCDH19 Mutations | Shinichi Hirose ,Japan | ||
| Dravet Syndrome: Update in 2013 | Ingrid Scheffer ,Australia | ||
| Genetic mechanisms in dev. brain malformations in infantile epilepsy | Hoon-Chul Kang , Korea, Repub. | ||
| Expanding genetic and molecular targets of epilepsy in infancy | Yuwu Jiang ,China | ||
| 10:30-12:30 | S06 | Leukoencephalopathies | |
| CATARATAS II | Chair: Deborah Renaud (USA) | ||
| Clinical approach to leukodystrophies | Sakkubai Naidu ,USA | ||
| Leukoencephalopathies associated with macrocephaly | Deborah Renaud ,USA | ||
| Peroxisomal leukoencephalopathy | Bwee-Tien Poll-The ,The Netherlands | ||
| 10:30-12:30 | S07 | Cerebral Palsy | |
| IGUAÇU I | Chairs: Pratibha Singhi (India) & Michael Johnston (USA) | ||
| 10:30 AM | Treatment of Cerebral Palsy and its management in resource poor conditions | Pratibha Singhi ,India | |
| 10:54 AM | Activity-based therapies and neuroplasticity | Diane Damiano, USA | |
| 11:18 AM | Heterogeniety of CP Population Based Perspectives | Michael Shevell ,Canada | |
| 11:42 AM | Management of Cerebral Palsy from an International perspective | Hans Forssberg ,Sweden | |
| 12:06 AM | Neuroprotection to reduce incidence of CP | Michael Johnston ,USA | |
| 10:30-12:30 | S08 | Childhood Headaches: Current Treatments and Research | |
| IGUAÇU II | Chair: Kenneth Mack (USA) | ||
| Chronic Daily Headache | Kenneth Mack ,USA | ||
| Autonomic Instability and Migraine: "I am tired, dizzy and my head hurts all the time!" | Eric M. Pearlman ,USA | ||
| Chronic Daily Headache | David Rothner ,USA | ||
| Headache and school | Marco Antônio Arruda ,Brazil | ||
| 12:30-14:00 | LUNCH / TRADE EXHIBITION / LUNCH TIME MEETINGS | ||
| 12:45-13:45 | ICNA Council of delegates meeting (closed session) - IGUAÇU I | ||
| PLATFORM SESSIONS | |||
| IGUAÇU I | |||
| 14:00-17:00 | DEVELOPMENT COGNITION AND PSYCHIATRY | ||
| Chair: TBA | |||
| 0200 - 0215 PM | FP51: Children with autsim and epilepsy:a descriptive clinical cohort study from south africa | Nerica Ramsundhar, South Africa | |
| 0215 - 0230 PM | FP52: Cognitive profile, neuropsychological disorders and concerns in patients with neurofibromatosis Type 1 | Maria Puga, Argentina | |
| 0230 - 0245 PM | FP53: Conners Continuous Performance Test profile in children with Attention Deficit Hyperactivity Disorder in relation to their intellectual performance | Maria Puga, Argentina | |
| 0245 - 0300 PM | FP54: Schooling of epileptic children. factors associated with the need for school support. | Marina Aberastury, Argentina | |
| 0300 - 0315 PM | FP55: FMR1 intron 1 methylation analysis: an epigenetic biomarker for the neurodevelopmental phenotype of children with Fragile X. | Marta Arpone, Australia | |
| 0315 - 0330 PM | FP56: The first European studies of lisdexamfetamine dimesylate in children with attention deficit/hyperactivity disorder | Claudia Gasparian, Brazil | |
| 0330 - 0345 PM | FP57: Pharmacokinetics and pharmacodynamics of the prodrug stimulant lisdexamfetamine dimesylate in children and adolescents with ADHD | Claudia Gasparian, Brazil | |
| 0345 - 0400 PM | FP58: Analysis of motor performance in infants with congenital hypothyroidism who began treatment in the first month of life | Môyra Patresi, Brazil | |
| 0400- 0415 PM | FP59: The importance of identifying neuropsychomotor delays in the development of young children | Marcia Valiati, Brazil | |
| 0415 - 0430 PM | FP60: Unexpected subclinical spikes: Clinical and Neurophysiological correlations | Mark Mintz, USA | |
| 0430 - 0445 PM | FP61: Modulation of the TMS-evoked N100 during a go/nogo task in children with ADHD | Paolo Curatolo, Italy | |
| 0445- 0500 PM | FP62: Correlation with urinary nonylphenol levels and clinical symptoms in children with attention-deficit hyperactivity disorder | Jung-Chieh Du, Taiwan | |
| IGUAÇU II | |||
| 14:00-17:00 | CNS INFECTIONS | ||
| Chair: TBA | |||
| 0200 - 0215 PM | FP65: Meningitis, Encephalitis, Myelitis and ADEM in Children: Automated Case Ascertainment (ChAT Analysis) in Real-Time | Patrick Obermeier, Germany | |
| 0215 - 0230 PM | FP64: Herpes-simplex encephalitis in patients with onco-hematological disease | Mariana González Suarez, Argentina | |
| 0230 - 0245 PM | FP63: Exogenous BDNF Improves Endogenous Neurogenesis Following Experimental Streptococcus Pneumoniae Meningitis | Ling Li, China | |
| 0245 - 0300 PM | FP66: Clinicoradiological outcomes in children with solitary neurocysticercosis with and without albendazole therapy: a retrospective case record analysis. | Sheffali Gulati, India | |
| 0300 - 0315 PM | FP67: CSF cultures / drug sensitivity in pediatric TBM - experience from a tertiary-care hospital in India | Vrajesh Udani, India | |
| 0315 - 0330 PM | FP68: Clinical Presentation and Prognosis of Pediatric Encephalitis : Experience of a Korean Single Tertiary Center | Jun-Sung Park, China | |
| 0330 - 0345 PM | FP69: Is that diagnostic lumbar puncture necessary? | Venkateswaran Ramesh, UK | |
| 0345 - 0400 PM | FP70: Shingles of the Brain-Recurrent Herpes Zoster Ophthalmicus causing arteriopathy and BasalGanglia Infarction | Jean-Pierre Lin, UK | |
| 0400- 0415 PM | FP71: Paediatric Bacterial Meningitis in Southern Nigeria | Angela Frank-Briggs, Nigeria | |
| 0415 - 0430 PM | FP72: Opportunities of emergency chemoprophylaxis of tick-borne encephalitis in children | Natalia Skripchenko, Russia | |
| 0430 - 0445 PM | FP73: Paradoxical reaction in the central nervous system after tuberculosis treatment in an immunocompromised child | Analia Pastrana, Argentina | |
| 0445- 0500 PM | FP74: Etio-pathogenetic therapy of viral encephalitis in children | Natalia Skripchenko, Russia | |
| CATARATAS I | |||
| 14:00-17:15 | NEUROIMMUNOLOGY | ||
| Chair: TBA | |||
| 0200 - 0215 PM | FP75: Clinical outcomes in children younger than 12 years with multiple sclerosis treated with subcutaneous interferon beta-1a: subgroup analysis of a retrospective study (REPLAY) | Silvia Tenembaum, Argentina | |
| 0215 - 0230 PM | FP76: Diagnosing childhood small vessel CNS vasculitis: A proposed histological tool. | Maryam Nabavi Nouri, Canada | |
| 0230 - 0245 PM | FP77: Non-traumatic acute myelophaty: a series of 76 cases | Hugo Arroyo, Argentina | |
| 0245 - 0300 PM | FP78: Utility and Safety of Rituximab in pediatric autoimmune and inflammatory CNS disease | Ming Lim, UK | |
| 0300 - 0315 PM | FP79Clinical and Demographic Features of 389 Children with OMS: an International Cohort | Elizabeth Tate, USA | |
| 0315 - 0330 PM | FP80: Pharmacodynamics of immunotherapy for opsoclonus-myoclonus syndrome: impact on cytokines/chemokines | Michael Pranzatelli, USA | |
| 0330 - 0345 PM | FP81: Voltage Gated Potassium Channel (VGKC)-complex antibodies in children: what do they mean? | Rahul Singh, UK | |
| 0345 - 0400 PM | FP82: The Clinical Impact of Acute Demyelination of the Central Nervous System in Children | Julia O'Mahony, Canada | |
| 0400- 0415 PM | FP83: Spectrum of MOG autoantibody-associated demyelinating diseases in pediatric patients | Silvia Tenembaum, Argentina | |
| 0415 - 0430 PM | FP84: Myelin oligodendrocyte glycoprotein (MOG) antibodies in children without oligoclonal bands predict a non-MS course of acquired demyelination syndrome (ADS). | Rahul Singh, UK | |
| 0430 - 0445 PM | FP85: Therapeutic plasma exchange in paediatric neurology: indications, side effects and outcomes from four UK tertiary centres | Cheryl Hemingway, UK | |
| 0445- 0500 PM | FP86: Clinical characteristics of Irish narcolepsy patients following H1N1 influenza epidemic and vaccination in 2009/2010 | Elaine Reade, Ireland | |
| 0500 - 0515 PM | FP87: Autoimmune encephalitis in children: experience of a tertiary care teaching hospital in North India | Rachna Dubey, India | |
| CATARATAS II | |||
| 14:00-17:00 | STROKE & NEUROVASCULAR DISORDERS / NEUROPROTECTION | ||
| Chair: TBA | |||
| 0200 - 0215 PM | FP88: Perinatal stroke risk factors: Syndrome-controlled analysis in the Canadian Cerebral Palsy Registry | Adam Kirton, Canada | |
| 0215 - 0230 PM | FP89: Profile of Childhood Cerebrovascular Outpatient Clinic at Hospital in the South of Brazil | Marcela Gonçalves, Brazil | |
| 0230 - 0245 PM | FP90: Neurological involvement in children with E.Coli 0104:H4 induced Haemolytic Uraemic Syndrome | Hans Hartmann, Germany | |
| 0245 - 0300 PM | FP91: Is D-dimer measurement useful in pediatric cerebral sinovenous thrombosis? | Mahendranath Moharir, Canada | |
| 0300 - 0315 PM | FP92: Role of prothrombotic risk factors (thrombophilia) in neonatal arterial ischemic stroke | Mahendranath Moharir, Canada | |
| 0315 - 0330 PM | FP93: Robotic quantification of proprioceptive dysfunction in children with perinatal stroke | Andrea Kuczynski, Canada | |
| 0330 - 0345 PM | FP94: Hemicerebellitis: presentation of three cases | Gabriela Reyes Valenzuela, Argentina | |
| 0345 - 0400 PM | FP95: Malignant Middle Cerebral Artery Infarction in Children | Andrea Andrade, Canada | |
| 0400- 0415 PM | FP96: Posterior reversible encephalopathy syndrome: retrospective analysis of a pediatric intensive care unit | Patricia Takahashi, Brazil | |
| 0415 - 0430 PM | FP97: Isolated Bilateral Carotid Arteritis Presenting With Stroke In Childhood | Kevin Shapiro, USA | |
| 0430 - 0445 PM | FP98: Long-term Neuropsychological Outcome after Childhood Cerebral Sinovenous Thrombosis | Mahendranath Moharir, Canada | |
| 0445- 0500 PM | FP99: Hypothermia in hypoxic ischemic encephalopathy preliminary results in neurodevelopmental outcome | Claudio Waisburg, Argentina | |
- Details